《大行報告》裏昂下調新創建(00659.HK)目標價至9元 評級「買入」
裏昂發表報告指,新創建(00659.HK)下半財年經常性利潤及股息仍低於該行預期,該行指期內隨着道路、飛機租賃及物流業務復甦,經常性利潤按年增長2.4倍,惟股息僅輕微增長,該行對此感失望。該行並認爲集團進行股份回購的機會不大。集團出售非核心資產後,該行相信收購非創建資產(non greenfield assets)是集團2022年財年資產部署的重點,尤其是看到本港旅遊限制及社交距離措施有早前放寬跡象。
裏昂維持新創建2022財年盈利預測,但將2023財年盈利預測削減6%,因認爲疫情將繼續挑戰其建築和設施管理業務,同時亦下調股息預測。目標價相應由10.10元降至9元,重申「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.